Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Thyroid Hormone Supplementation in Patients With Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial update on thyroid hormone supplementation in patients with euthyroid sick syndrome and septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thyroid hormone supplementation

Snippet

Sponsor: Cantonal Hospital Zenica | Conditions: Euthyroid Sick Syndromes, Septic Shock | Phase 2 | Status: COMPLETED